Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Medical Clinics of North America|December 3, 2014
Glycemic targets: what is the evidence?Silvio Inzucchi, Sachin Majumdar
Diabetes & Vascular Disease Research|February 2, 2019
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetesRalph A DeFronzo, Silvio Inzucchi, Muhammad Abdul-Ghani, et al.
Journal of Critical Care|August 6, 2014
The prevalence of undiagnosed diabetes mellitus and the association of baseline glycemic control on mortality in the intensive care unit: a prospective observational studyQuynh N Hoang, Margaret A Pisani, Silvio Inzucchi, et al.
Journal of General Internal Medicine|July 1, 2006
BRIEF REPORT: nutrition and weight loss information in a popular diet book: is it fact, fiction, or something in between?Sarah L Goff, Joanne M Foody, Silvio Inzucchi, et al.
Cardiovascular Diabetology|November 21, 2023
Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular diseaseXi Tan, Yuanjie Liang, Jigar R Rajpura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 9, 2016
Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary CareBrian Lee, Dace Trence, Silvio Inzucchi, et al.
The Journal of Clinical Investigation|May 22, 2002
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetesRipudaman S Hundal, Kitt F Petersen, Adam B Mayerson, et al.
The American Journal of Cardiology|April 3, 2023
Persistence on Novel Cardioprotective Antihyperglycemic Therapies in the United StatesArash A Nargesi, Callahan Clark, Arya Aminorroaya, et al.
BMJ Open|November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Pageof 1